One particular GR target gene, serum and glucocorticoid-regulated kinase 1 (SGK1) has been shown to have a prominent role in ENZ resistance (Isikbay et al. 2014); inhibition of SGK1 decreased PCa cell viability, while its overexpression increased tumor initiation. The gene discussed is SGK1; the disease is posterior cortical atrophy.